Background: Correlation of cytologic and ultrasound findings is extremely valuable for the cytopathologist in management of thyroid nodules.
Methods: Ultrasound scans (US) of all thyroid FNA taken over a 13 month period and reported by a single cytologist were reviewed at the time of reporting, focusing on aspirates that were nondiagnostic/unsatisfactory, equivalent to Bethesda Class I, UK Royal College of Pathologists Class Thy1 or Thy1c.
Results: FNA cases [68 (40.7%)] were classified as Thy1, equivalent to Bethesda Class I. US of 3 Thy1 cases were not available for review. On cytologist US review 9 cases were classified as pure cystic, 28 as mixed cystic/solid, 12 as predominantly solid/focally cystic and 16 as purely solid. 27 (41.5%) of cases on cytological assessment were Thy1 and showed no evidence of a cyst on US, 17 (26.1%) were Thy1/Thy1c showing features suggestive of a possible cyst and 21 (32.3%) were
Thy1c showing definite features of a cyst. Fifteen of 16 (93.7%) of pure solid cases on US were Thy1, equivalent to Bethesda Class I and all 9 (100%) of cases that were pure cystic on US were reported as Thy1c-equivalent to Bethesda Category I-cyst fluid only (P < .001).
Conclusion: Cytopathologist review of thyroid US is extremely useful and can be helpful in triaging patients for further management in cases of solid, mixed cystic and/or solid, and pure cystic thyroid lesions with non-diagnostic/unsatisfactory thyroid FNA. Statistical analysis was performed using Statistica Academic version 13.2 Tibco Software Inc., Palo Alto, CA. FNA's. In 3 cases, the ultrasound images were not available for review as these had not been uploaded onto the computer server at the time of ultrasound examination and these images could not be retrieved. Of the 65 remaining cases that were either Thy1, Thy1/Thy1c or Thy1c
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and that are the basis of this article; 9 were classified by the author on review of the US as pure cystic, 28 were classified as mixed cystic/solid, 12 as predominantly solid/focally cystic and 16 as purely solid (Table 1) .
There was no statistically significant trend across the whole group of 65 non-diagnostic thyroid FNAs when cases that were either mixed cystic/solid or predominantly solid/focally cystic were included, v 2 test NS. If the mixed cystic/solid and the predominantly solid/focally cystic cases were excluded from the analysis, 15 of 16 (93.7%) of the cases that appeared purely solid on ultrasound were reported as Thy1-equivalent to Bethesda class I and all 9 cases (100%) pure cystic on ultrasound were reported as Thy 1c, equivalent to Bethesda class I-'cyst fluid only,'
Fisher's exact test P > .001. Of the 28 cases that on ultrasound appeared mixed cystic/solid, 5 were reported as Thy1, 12 as Thy1/ Thy1c and 11 as Thy1c. Of the predominantly solid/focally cystic, 7 cases were reported as Thy1, 4 cases as Thy1/Thy 1c, and 1 case as Thy 1c.
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This brief study suggests that it can be useful for a reporting pathologist can be achieved. In this small prospective study all the cases that on ultrasound were purely cystic showed appearances in keeping with cyst fluid only, and lesions that on ultrasound appeared purely solid on ultrasound were in almost all cases were reported as Thy1.
It is also worth commenting that in the UK Royal College of Pathologists Terminology as also in The Bethesda System for Reporting
Thyroid FNA cytology the non-diagnostic/unsatisfactory criteria are virtually identical. In the Bethesda system a non-diagnostic/unsatisfactory aspirate typically comprises fewer than six groups of well-preserved well-stained follicular epithelial cells, or is poorly prepared, poorly stained, or shows obscured follicular cells, or is a cyst fluid, whether without histiocytes or fewer than 6 groups of 10 benign follicular cells. 8 The Bethesda System for Reporting Thyroid Cytology: Definitions,
Criteria and Explanatory Notes states that in the proper clinical setting for example, ultrasound evidence of a simple unilocular cyst, cyst fluid only specimens may be considered clinically adequate even though they are reported as non-diagnostic/unsatisfactory. 8 In summary, in the appropriate clinical setting, cytopathological assessment of thyroid FNA can usefully be extended to include the cytologist's review of the US prior to issuing of the cytopathology report, if the cytopathologist sufficient expertise and training in US interpretation.
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